In the PDGFRA D842V-mutant population, the ORR was 91% and the disease control rate was 98% (CR = 13%, PR = 79%, SD = 6%), which is the best achievement ever reached for this GIST molecular subtype [89]. Here, PDGFRA is linked to gastrointestinal stromal tumor.